Long-Term Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice.

Tural, DenizArslan, CagataySelcukbiricik, FatihOlmez, Omer FatihErman, MustafaUrun, YukselKaradurmus, Nuri2023-06-162023-06-1620220732-183X1527-7755https://doi.org/10.1200/JCO.2022.40.6_suppl.474https://hdl.handle.net/20.500.14365/2275[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessLong-Term Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice.Conference Object10.1200/JCO.2022.40.6_suppl.474